Press Releases :: BiomX, Inc. (PHGE)

Jun 14, 2021 6:30am EDT

BiomX Presents Preclinical Results With BX005 for Atopic Dermatitis at the Revolutionizing Atopic Dermatitis 2021 Virtual Conference and the International Conference on Phage Therapy and Bacteriophages

Jun 09, 2021 6:30am EDT

BiomX to Present Preclinical Results with BX004 in Cystic Fibrosis at the 44th European Cystic Fibrosis Conference

May 24, 2021 6:30am EDT

BiomX Reports First Quarter 2021 Financial Results and Provides Business Updates

May 18, 2021 8:00am EDT

BiomX To Host Key Opinion Leader Event on BX003 for the Treatment of Inflammatory Bowel Disease

May 18, 2021 6:30am EDT

BiomX to Host First Quarter 2021 Financial Results Conference Call and Webcast on May 24, 2021

Apr 20, 2021 7:00am EDT

BiomX to Present at Upcoming April Investor Events

Mar 31, 2021 6:30am EDT

BiomX Reports Fourth Quarter and Full Year 2020 Financial Results and Provides Business Update

Mar 24, 2021 6:30am EDT

BiomX to Report Fourth Quarter and Full Year 2020 Financial Results on March 31, 2021

Mar 02, 2021 7:00am EST

BiomX Announces Dosing of First Subject in Phase 2 Study of BX001 for Acne-Prone Skin

Mar 01, 2021 7:00am EST

BiomX to Present at Upcoming March Investor Conferences

Previous
1…
4
5
6
7
8
9
10
11
12
13
Next

Investor Contact Information

Company

BiomX, Inc.
708 Quince Orchard Rd
Suite 205
Gaithersburg, MD 20878
USA
info@biomx.com

Investor Relations

Ben Cohen
benc@biomx.com